Promilless

📍 Oulu, Finland🗓 Founded 2020👥 3 employees💰 Last funded Jul 2020
Biotechnology🌐 promilless.com
Website LinkedIn
Testing within human body substances are expensive, invasive and often complicated - by leveraging the technology of intelligent enzymic paper diagnostics we simplify the equation for you. Promilless has created a revolutionary platform for enzymatic testing using intelligent paper technology coupled with innovative biochemistry. Promilless products are manufactured by printing, innovatively combining high-quality testing methods with high-throughput and low-cost production. Promilless has launched its first commercial product: non-invasive enzymatic alcohol test. The development pipeline expands the tests selection into well being, medical and toxicological products including glucose, creatinine and drugs of abuse measurements.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
1
Frequently asked questions
Who invested in Promilless?
Promilless has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Promilless last raise funding?
The most recent investment in Promilless recorded on gritt.io was in July 2020.
When was Promilless founded?
Promilless was founded in 2020.
What industry is Promilless in?
Promilless operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Promilless based?
Promilless is headquartered in Oulu, Finland.